Search results
EHA 2024: Novartis Scemblix takes on all TKIs in head-to-head CML trial
Clinical Trials Arena via Yahoo Finance· 5 days agoThe introduction of the first-generation BCR-ABL1 tyrosine kinase inhibitor (TKI), Novartis's...
Onex Canada Asset Management Inc. Has $5.63 Million Stock Holdings in Novartis AG (NYSE:NVS)
ETF DAILY NEWS· 7 days agoOnex Canada Asset Management Inc. lowered its position in shares of Novartis AG (NYSE:NVS – Free Report) by 30.5% in the fourth quarter, Holdings Channel reports. The institutional ...
Jazz drug for tremor fails study; Radiopharma drug developer ITM swaps CEOs
BioPharma Dive via Yahoo Finance· 18 hours agoA medicine Jazz acquired in 2019 missed the goal of a Phase 2 study. Elsewhere, Vanda rejected two...
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
Zacks via Yahoo Finance· 17 hours agoSome popular names in the pharma sector are Pfizer, Johnson & Johnson, Merck, AbbVie, Novartis and...
Cellect Your Weapon: Navigating Potential Arguments in the Aftermath of In re Cellect
The National Law Review· 15 hours agoThe Patent Trial & Appeal Board found several related Cellect patents invalid for ODP in view of...
Here's Why Eli Lilly (LLY) is Probably the Best Drug Stock Now
Zacks via Yahoo Finance· 2 days agoSome popular names in the pharma sector are Pfizer PFE, Johnson & Johnson JNJ, Novo Nordisk NVO,...
Tectonic bets on GPCR heart failure drug following reverse merger with Avrobio
Pharmaceutical Technology via Yahoo Finance· 15 hours agoThe company’s money woes started last year when it stopped development work on its gene therapy...
Top 5 Small-Cap Biotechnology Stocks for a Stable Portfolio
Zacks via Yahoo Finance· 17 hours agoFurther, BCYC collaborates with biopharmaceutical companies and organizations to develop programs in...
Investing in the heart of Central Europe - Foreign Policy
Foreign Policy Magazine· 6 days agoSituated in the heart of Europe, Hungary represents a beacon of economic resilience and investment...
Here's Why Novartis (NVS) is a Strong Momentum Stock
Zacks· 2 days agoFor new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...